Larson Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Larson Financial Group's BIIB Position: Q1 2026 in Review
Larson Financial Group increased its Biogen (BIIB) stake by 31% in Q1 2026, buying an estimated $38K and bringing the position to 881 shares worth $162K. The position accounts for 0.01% of the portfolio, ranked #788.
Larson Financial Group first reported a position in BIIB in Q4 2018 and has held it in 22 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Larson Financial Group held 881 shares of Biogen worth $162K as of Q1 2026.
- Larson Financial Group bought 206 Biogen shares in Q1 2026, an estimated $38K.
- Biogen made up 0.01% of Larson Financial Group's portfolio in Q1 2026, its #788 holding.
- Larson Financial Group first reported a position in Biogen in Q4 2018 and has held it in 22 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.